New technology aims to speed up medicine development by helping scientists design and test drugs faster
New York, United States, 16 April 2026 – Amazon...
Strategic manufacturing partnership supports late-stage development of promising immunotherapy drug
Basel, 9 April 2026 – ImmuneOncia Therapeutics, a clinical-stage biopharmaceutical company, has partnered with Lonza,...
The AI drug discovery unicorn aims to move beyond early research and build fully autonomous intelligence for real-world clinical development.
Beijing, 4 February 2026 –...
The investment will support advanced human-like cell models for neuroscience, eye, and heart research.
Edinburgh, Scotland, 14 January 2026 - Axol Bioscience Ltd. (Axol), a...